Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can six group sessions help women with cancer manage distress?

NCT ID NCT07837440

Symptom relief Sponsor: Ardakan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Researchers are testing whether a structured group program can reduce anxiety, depression, and cognitive avoidance and improve a sense of coherence in women with early-stage cancer. Forty women who finished at least one course of cancer treatment join either the program or standard care. The program runs six weekly 90-minute sessions covering stress management, cognitive restructuring, and emotional regulation, with assessments at the start, after six weeks, and two months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a structured group psychoeducational program with six weekly 90-minute sessions on stress management, cognitive restructuring, and emotional regulation
What this could lead to
If it helps, this program could become a low-cost addition to routine cancer care, giving women practical tools to manage anxiety and depression alongside their medical treatment.
What could go wrong
The trial is small, with 40 women in early-stage cancer, so results may not apply to other patients or cancer types. Group programs also depend on attendance, and any benefits may fade after the sessions end.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Sep 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Minimum age of 20 years * Diagnosis of cancer in stages 1 or 2 confirmed by a physician * Having completed at least one course of cancer treatment * Not currently receiving any other psychological treatment or intervention * Minimum literacy (ability to read and write) * Written informed consent to participate in the study Exclusion Criteria: * Unwillingness to continue participation * Absence from more than two sessions * Receiving other psychological interventions concurrently with cancer treatment * Major psychiatric or cognitive disorder that prevents providing informed consent and participating in the study * Death of the patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder cancer Depression neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

Contacts and locations

Locations

  • Ayatollah Yasrebi Hospital

    Kāshān, Isfahan, 8714883745, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.